MBX

MBX Biosciences, Inc. Common Stock

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Aynechi TibaDirector
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88
Ryder StevenDirector
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88
Hoerter Steven L.Director
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88
Stelzer LaurieDirector
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88
Heron Patrick JDirector, 10 Percent Owner:
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88
Pescovitz Ora H.Director
--12.5k shares
Grant / ExerciseJun 4, 2026
$386.4K12.5k shares
$30.91
$31.88

News

globenewswire.comMBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026globenewswire.comJun 1fool.comChief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Runfool.comMay 27globenewswire.comMBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York Cityglobenewswire.comMay 26seekingalpha.comMicrobix Biosystems Inc. (MBX:CA) Q2 2026 Earnings Call Transcriptseekingalpha.comMay 14seekingalpha.comMBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics Portfolio Transcriptseekingalpha.comMay 11